Trials / Unknown
UnknownNCT04883970
CLDN18.2 Targeting PET Imaging in Patients With Gastrointestinal Tumors
CLDN18.2 Targeting 124I-18B10(10L) PET Imaging in Patients With Gastrointestinal Tumors
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to constrcut a noninvasive approach 124I-18B10(10L) PET/CT to detect the CLDN18.2 expression of tumor lesions in patients with gastrointestinal tumors and to identify patients benefiting from CLDN18.2 targeting treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 124I-18B10(10L) PET/CT | Study participants will undergo 124I-18B10(10L) PET/CT scans |
Timeline
- Start date
- 2021-05-13
- Primary completion
- 2024-05-01
- Completion
- 2024-05-01
- First posted
- 2021-05-12
- Last updated
- 2024-01-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04883970. Inclusion in this directory is not an endorsement.